Pioglitazone Improves Fatty Liver in Prediabetes, Diabetes Pioglitazone Improves Fatty Liver in Prediabetes, Diabetes
Results of a single-center randomized trial suggest the drug may halt NASH progression and alter the natural history of the disease. Medscape Medical News
Source: Medscape Gastroenterology Headlines - Category: Gastroenterology Tags: Gastroenterology News Source Type: news
More News: Actos | Diabetes | Endocrinology | Fatty Liver Disease (FLD) | Gastroenterology | Liver | Urology & Nephrology